Stay updated on p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.

Latest updates to the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedAdded 'Small cell lung carcinoma' as a keyword in the study metadata.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedHepatocellular carcinoma was added as a related topic, and the page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page content and layout appear unchanged between the two screenshots. No new elements or removals are visible.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Gastric cancer as a listed condition/MeSH term in the study record. This broadens the documented scope of cancers associated with the trial.SummaryDifference0.0%

- Check51 days agoChange DetectedA new revision tag v3.4.2 was added and the previous government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.